• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hippo 通路靶标 YAP 通过其 TEAD 相互作用结构域促进转移。

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

机构信息

Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2441-50. doi: 10.1073/pnas.1212021109. Epub 2012 Aug 13.

DOI:10.1073/pnas.1212021109
PMID:22891335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3443162/
Abstract

The transcriptional coactivator Yes-associated protein (YAP) is a major regulator of organ size and proliferation in vertebrates. As such, YAP can act as an oncogene in several tissue types if its activity is increased aberrantly. Although no activating mutations in the yap1 gene have been identified in human cancer, yap1 is located on the 11q22 amplicon, which is amplified in several human tumors. In addition, mutations or epigenetic silencing of members of the Hippo pathway, which represses YAP function, have been identified in human cancers. Here we demonstrate that, in addition to increasing tumor growth, increased YAP activity is potently prometastatic in breast cancer and melanoma cells. Using a Luminex-based approach to multiplex in vivo assays, we determined that the domain of YAP that interacts with the TEAD/TEF family of transcription factors but not the WW domains or PDZ-binding motif, is essential for YAP-mediated tumor growth and metastasis. We further demonstrate that, through its TEAD-interaction domain, YAP enhances multiple processes known to be important for tumor progression and metastasis, including cellular proliferation, transformation, migration, and invasion. Finally, we found that the metastatic potential of breast cancer and melanoma cells is strongly correlated with increased TEAD transcriptional activity. Together, our results suggest that increased YAP/TEAD activity plays a causal role in cancer progression and metastasis.

摘要

转录共激活因子 Yes 相关蛋白(YAP)是脊椎动物器官大小和增殖的主要调节因子。因此,如果 YAP 的活性异常增加,它可以在几种组织类型中充当致癌基因。尽管在人类癌症中没有发现 yap1 基因的激活突变,但 yap1 位于 11q22 扩增子上,该扩增子在几种人类肿瘤中被扩增。此外,已经在人类癌症中鉴定出 Hippo 通路成员的突变或表观遗传沉默,该通路抑制 YAP 功能。在这里,我们证明除了增加肿瘤生长外,YAP 活性的增加在乳腺癌和黑色素瘤细胞中具有很强的促转移作用。我们使用基于 Luminex 的方法进行多重体内测定,确定与 TEAD/TEF 转录因子家族相互作用但不与 WW 结构域或 PDZ 结合基序相互作用的 YAP 结构域对于 YAP 介导的肿瘤生长和转移是必需的。我们进一步证明,通过其 TEAD 相互作用结构域,YAP 增强了已知对肿瘤进展和转移很重要的多个过程,包括细胞增殖、转化、迁移和侵袭。最后,我们发现乳腺癌和黑色素瘤细胞的转移潜力与 TEAD 转录活性的增加密切相关。总之,我们的研究结果表明,YAP/TEAD 活性的增加在癌症进展和转移中起因果作用。

相似文献

1
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.Hippo 通路靶标 YAP 通过其 TEAD 相互作用结构域促进转移。
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2441-50. doi: 10.1073/pnas.1212021109. Epub 2012 Aug 13.
2
The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.Yes 相关蛋白的 PDZ 结合基序对于其与 TEAD 介导的 CTGF 转录和致癌细胞转化活性的共激活作用是必需的。
Biochem Biophys Res Commun. 2014 Jan 17;443(3):917-23. doi: 10.1016/j.bbrc.2013.12.100. Epub 2013 Dec 28.
3
Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.靶向 Hippo 通路通过使用环状 YAP 样肽特异性阻断 YAP-TEAD 相互作用。
FASEB J. 2015 Feb;29(2):724-32. doi: 10.1096/fj.14-262980. Epub 2014 Nov 10.
4
Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.Yes相关蛋白的生长刺激和致癌转化活性需要TEAD结合域和WW结构域。
Cancer Res. 2009 Feb 1;69(3):1089-98. doi: 10.1158/0008-5472.CAN-08-2997. Epub 2009 Jan 13.
5
Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.对内在无序的YAP蛋白与转录因子TEAD之间相互作用的剖析。
Elife. 2017 Apr 21;6:e25068. doi: 10.7554/eLife.25068.
6
TEAD mediates YAP-dependent gene induction and growth control.TEAD介导YAP依赖性基因诱导和生长调控。
Genes Dev. 2008 Jul 15;22(14):1962-71. doi: 10.1101/gad.1664408. Epub 2008 Jun 25.
7
MRTF potentiates TEAD-YAP transcriptional activity causing metastasis.MRTF增强TEAD-YAP转录活性,导致转移。
EMBO J. 2017 Feb 15;36(4):520-535. doi: 10.15252/embj.201695137. Epub 2016 Dec 27.
8
Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics.MRTF-SRF和YAP-TEAD信号通路在癌症相关成纤维细胞中的相互依赖性是间接的,并且由细胞骨架动力学介导。
Genes Dev. 2017 Dec 1;31(23-24):2361-2375. doi: 10.1101/gad.304501.117. Epub 2018 Jan 9.
9
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.TEAD4的酰化对其与共激活因子YAP和TAZ相互作用的影响。
Protein Sci. 2017 Dec;26(12):2399-2409. doi: 10.1002/pro.3312. Epub 2017 Nov 11.
10
c-Abl antagonizes the YAP oncogenic function.c-Abl拮抗YAP的致癌功能。
Cell Death Differ. 2015 Jun;22(6):935-45. doi: 10.1038/cdd.2014.182. Epub 2014 Oct 31.

引用本文的文献

1
Pharmacological Targeting of DHHC9-Mediated STRN4 Palmitoylation to Suppress YAP-Driven Cancer Metastasis.靶向DHHC9介导的STRN4棕榈酰化以抑制YAP驱动的癌症转移的药理学研究
J Cell Mol Med. 2025 Sep;29(17):e70815. doi: 10.1111/jcmm.70815.
2
Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond.靶向Hippo/YAP信号通路:癌症治疗及其他领域的一种有前景的方法。
MedComm (2020). 2025 Aug 29;6(9):e70338. doi: 10.1002/mco2.70338. eCollection 2025 Sep.
3
Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses -mutant mesothelioma.评估YAP-TEAD抑制剂的流程表明,TEAD抑制可抑制-突变型间皮瘤。
Life Sci Alliance. 2025 Jul 31;8(10). doi: 10.26508/lsa.202503241. Print 2025 Oct.
4
Recent advances in novel targeting mechanisms for colorectal cancer.结直肠癌新型靶向机制的最新进展
Clin Transl Oncol. 2025 Jul 11. doi: 10.1007/s12094-025-03990-2.
5
The polarity protein Par3 enhances renal cell carcinoma metastasis YAP/TAZ activation.极性蛋白Par3增强肾细胞癌转移中的YAP/TAZ激活。
Cancer Biol Med. 2025 Jul 8;22(7):812-31. doi: 10.20892/j.issn.2095-3941.2024.0297.
6
Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potential.剖析肝细胞癌中TEAD1的多组学格局:细胞周期调控与转移潜能
Front Immunol. 2025 Jun 5;16:1567969. doi: 10.3389/fimmu.2025.1567969. eCollection 2025.
7
Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes.二元YAP开启/ YAP关闭癌症类别分子基础及治疗意义
Biochem J. 2025 May 28;482(11):741-61. doi: 10.1042/BCJ20253077.
8
YAP controls cell migration and invasion through a Rho GTPase switch.YAP通过Rho GTPase开关控制细胞迁移和侵袭。
Sci Signal. 2025 May 27;18(888):eadu3794. doi: 10.1126/scisignal.adu3794.
9
Synphilin-1 regulates mechanotransduction in rigidity sensing through interaction with zyxin.α-突触核蛋白-1通过与桩蛋白相互作用调节硬度感知中的机械转导。
J Nanobiotechnology. 2025 May 14;23(1):345. doi: 10.1186/s12951-025-03429-4.
10
Integration of focal adhesion morphogenesis and polarity by DOCK5 promotes YAP/TAZ-driven drug resistance in TNBC.DOCK5通过整合粘着斑形态发生和极性促进三阴性乳腺癌中YAP/TAZ驱动的耐药性。
Mol Omics. 2025 May 12. doi: 10.1039/d4mo00154k.

本文引用的文献

1
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.遗传和药理学破坏 TEAD-YAP 复合物可抑制 YAP 的致癌活性。
Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7.
2
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.细胞脱离通过细胞骨架重排激活 Hippo 通路,从而诱导细胞凋亡。
Genes Dev. 2012 Jan 1;26(1):54-68. doi: 10.1101/gad.173435.111.
3
Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.Yes 相关蛋白在头颈部鳞状细胞癌淋巴结转移中的表达。
PLoS One. 2011;6(11):e27529. doi: 10.1371/journal.pone.0027529. Epub 2011 Nov 9.
4
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.Hippo 信号转导通路的效应物 TAZ 赋予乳腺癌细胞癌症干细胞相关特性。
Cell. 2011 Nov 11;147(4):759-72. doi: 10.1016/j.cell.2011.09.048.
5
Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer.Yes 相关蛋白促进腔上皮来源的乳腺癌肿瘤发生。
Eur J Cancer. 2012 May;48(8):1227-34. doi: 10.1016/j.ejca.2011.10.001. Epub 2011 Nov 5.
6
PP1A-mediated dephosphorylation positively regulates YAP2 activity.PP1A 介导的去磷酸化正向调节 YAP2 活性。
PLoS One. 2011;6(9):e24288. doi: 10.1371/journal.pone.0024288. Epub 2011 Sep 1.
7
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation.致癌性 YAP 通过 IGF2 介导的 Akt 激活促进髓母细胞瘤的放射抗性和基因组不稳定性。
Oncogene. 2012 Apr 12;31(15):1923-37. doi: 10.1038/onc.2011.379. Epub 2011 Aug 29.
8
Hippo pathway regulation by cell morphology and stress fibers.Hippo 通路受细胞形态和应激纤维的调节。
Development. 2011 Sep;138(18):3907-14. doi: 10.1242/dev.070987. Epub 2011 Aug 10.
9
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.E-钙黏蛋白通过 Hippo 信号通路组分介导接触抑制增殖。
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5. doi: 10.1073/pnas.1103345108. Epub 2011 Jul 5.
10
Role of YAP/TAZ in mechanotransduction.YAP/TAZ 在机械转导中的作用。
Nature. 2011 Jun 8;474(7350):179-83. doi: 10.1038/nature10137.